
AstraZeneca and Bristol Myers Squibb consider $400B merger to create pharma giant
UK pharmaceutical company AstraZeneca is in talks to merge with US rival Bristol Myers Squibb, potentially forming a combined entity valued at around $400 billion. The merger would be one of the largest in history, combining AstraZeneca's global reac...

